A study by The Baker Institute for Public Policy highlights the critical role of immigrant healthcare professionals in the U.S. health system, examining their increasing presence and the impact of legal pathways like the J-1 Visa Exchange Visitor Program.
J&Js Rybrevant plus Lazcluze combination gets FDA approval in NSCLC – Pharmaceutical Technology
The FDA has approved J&Js Rybrevant plus Lazcluze to treat patients with certain types of NSCLC. Credit: Nattakorn_Maneerat via Shutterstock. Johnson & Johnson’s (J&J) Rybrevant